title: Re: Francesco Piva, Matteo Santoni, Marina Scarpelli, et al's Letter to the Editor re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4.
authors.affiliation: Servizo de Oncoloxía Médica, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain. Electronic address: jurruba@gmail.com.
authors.forename: Juan
authors.initials: J
authors.lastname: Ruiz-Bañobre
authors.affiliation: Servizo de Oncoloxía Médica, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
authors.forename: Urbano
authors.initials: U
authors.lastname: Anido
authors.affiliation: Servizo de Oncoloxía Médica, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
authors.forename: Jorge
authors.initials: J
authors.lastname: García-González
mesh_terms: D000911:Antibodies, Monoclonal; D051017:Apoptosis Regulatory Proteins; D002292:Carcinoma, Renal Cell; D006801:Humans; D007680:Kidney Neoplasms; D000077594:Nivolumab
chemical_list: D000911:Antibodies, Monoclonal; D051017:Apoptosis Regulatory Proteins; D000077594:Nivolumab